InSound XT Gets FDA Nod To Become First Extended-Wear Hearing Aid
This article was originally published in The Gray Sheet
Executive Summary
InSound Medical intends to create an installment payment plan for its InSound XT Series extended-wear disposable hearing aid, to be priced competitively with high-end digital aids in the $3,000 range
You may also be interested in...
Symphonix Plans Vibrant SoundBridge Postmarket Surveillance Study
Symphonix Devices will conduct an 18-month postmarket surveillance study of patients implanted with the Vibrant P and Vibrant D Soundbridge implantable middle-ear hearing devices. FDA approved the products on Aug. 31.
EU Regulatory Assessors Get AI Boost In Reaching Scientific Decisions
The European Medicines Agency is training scientific staff working for the European medicines regulatory network in how to use a new AI-powered search engine that allows them to easily retrieve information on regulatory precedents.
EU Parliament Stricter Than Council On Medicines And Medical Devices Packaging
The EU Parliament's Environment, Public Health and Food Safety committee takes a compromise position with regards to the Packaging and Packaging Waste Directive. Medicines and medical devices should be exempt, but only until 2035, at which point the European Commission should check whether the development of materials and the recycling process have progressed, and may adjust this exemption accordingly.